MEDPACTO
MedPacto is a genome-based drug discovery and clinical-stage biotechnology company that is pursuing the development of first-in-class therapies to bring new hope to patients suffering from the most challenging diseases such as cancer. Vactosertib, an orally bioavailable small-molecule inhibitor of the TGF-type I receptor (TRI) that is currently in phase II clinical trials with global pharmaceutical companies such as Merck and AstraZeneca, is the leading drug candidate.
MEDPACTO
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2013-06-19
Address:
Seocho, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.medpacto.com
Total Employee:
51+
Status:
Active
Contact:
+82 2 6938 0200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Korea Telecom Cafe24 DNS SK Broadband
Similar Organizations
Geno Biotech
Geno Biotech is a pioneer in the field of precision medicine and is the first biotech company
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Current Employees Featured
Stock Details
Company's stock symbol is KRX:235980
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-24 | MedPacto Hires Global Clinical Expert Timothy R. Allen as Executive Vice President |
Official Site Inspections
http://www.medpacto.com Semrush global rank: 3.92 M Semrush visits lastest month: 3.23 K
- Host name: 183.111.138.201
- IP address: 183.111.138.201
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
Loading ... 